Skip to main content
ToolsForensic Analysisaurobindo pharma

aurobindo pharma

Supplier Forensic Analysis · Scanned: 2026/04/06

Disclaimer: Statistical patterns flagged for review only. This tool does not determine or imply wrongdoing. All findings require independent verification.
Risk Score
0RISK SCORE
LOW RISK
Compliance
N/A/100
Awards
2
Total Value
R 2,5B

Recent Awards

2 awards · Total: R 2 512 340 221

Showing 5 of 2
HP13-2025ARV: Supply and Delivery of Anti-Retroviral Medicines to the Department of Health for the period 1 July 2025 to 30 June 2028
Health
Ref: HP13-2025ARV
R 1 755 264 016
20 Aug 2025
HP13-2022ARV/01: Supply and Delivery of Anti-Retroviral Medicines to the Department of Health for the period ending 30 June 2025.
Health
Ref: HP13-2022ARV/01
R 757 076 205
24 Jun 2024

Risk Assessment

0RISK SCORE
LOW RISK

Based on 0 forensic flags detected

Unlock Full Analysis

Get access to all forensic flags, evidence details, and AI-generated audit narratives.

View Full Intelligence Report

Get complete award history, director network, and compliance analysis.

View Report →